We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$911M
AUM Growth
-$128M
Cap. Flow
-$82.6M
Cap. Flow %
-9.07%
Top 10 Hldgs %
73.8%
Holding
28
New
5
Increased
6
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$44.1M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$38M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$30.7M
4
MYGN icon
Myriad Genetics
MYGN
+$26.8M
5
NVDQ
Novadaq Technologies Inc.
NVDQ
+$21.9M

Top Sells

Rank Stock Value
1
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$61.9M
2
AKRX
Akorn Inc
AKRX
+$60M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$52.3M
4
UTHR icon
United Therapeutics
UTHR
+$30.4M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$28.2M

Sector Composition

Rank Sector Weight
1 Healthcare 95.96%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
26
Ironwood Pharmaceuticals
IRWD
$614M
– –
-3,936,068
Closed -$52.3M
OFIX icon
27
Orthofix Medical
OFIX
$477M
– –
-634,496
Closed -$27.1M
AKRX
28
DELISTED
Akorn Inc
AKRX
– –
-2,200,000
Closed -$60M
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Consonance Capital Management held 28 positions worth $911M, down 12% from $1.04B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Consonance Capital Management withdrew a net $82.6M in Q4 2016, closing 5 positions and reducing 9 holdings. Its most notable exit was Akorn Inc, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 93% a quarter earlier, followed by Financials.

Against the trend, Consonance Capital Management opened a new position in AMAG Pharmaceuticals worth $35.7M.

  • Consonance Capital Management's largest Q4 2016 buy was AMAG Pharmaceuticals: 1,026,902 shares worth $35.7M.
  • Consonance Capital Management added most to AtriCure in Q4 2016, an estimated $44.1M increase.
  • Consonance Capital Management's biggest Q4 2016 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $61.9M.
  • Consonance Capital Management fully exited Akorn Inc in Q4 2016, selling an estimated $60M.
  • Consonance Capital Management's ten largest holdings make up 74% of its $911M portfolio in Q4 2016.
  • Consonance Capital Management opened 5 new positions and closed 5 in Q4 2016.
  • Consonance Capital Management's portfolio value fell 12% quarter-over-quarter to $911M.

Based on Consonance Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.